Document Actions
BioPharma Alliance Fall Conference 2009
Fundamental changes are happening and they are happening fast. Collaborative networks are quickly emerging as an important new business model for biopharma. Companies that develop the flexibility and agility to learn new ways of working with partners will survive and thrive in the new environment. Smaller companies, including biotech and diagnostic start-ups, which develop the right collaborative capabilities will find new opportunities and resources by tapping into these innovation networks.
Join colleagues and members of the ASAP Biopharm Council as we explore the changes occurring in health care and their implications on alliances and other collaborations within the BioPharma industry.